Human neurexin-3α antibodies associate with encephalitis and alter synapse development

Neurology

Volumn 86, Issue 24, 2016, Pages 2235-2242

  Gresa Arribas, Nuria ^a,g   Planagumà, Jesús ^a   Petit Pedrol, Mar ^a   Kawachi, Izumi ^b   Katada, Shinichi ^b   Glaser, Carol A ^c   Simabukuro, Mateus M ^d   Armangué, Thaís ^a,e   Martínez Hernández, Eugenia ^a   Graus, Francesc ^a   Dalmau, Josep ^a,e,f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NIIGATA UNIVERSITY   (Japan)

^c OAKLAND UNIVERSITY   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CELL ADHESION MOLECULE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; NEUREXIN 3 ALPHA AUTOANTIBODY; UNCLASSIFIED DRUG; LRRTM2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; NEUREXIN IIIALPHA;

ADULT; ALLERGIC ENCEPHALITIS; ARTICLE; ASSISTED VENTILATION; AUTOIMMUNITY; AUTOPSY; BRAIN EDEMA; BRAIN FUNCTION; CELL FUNCTION; CELL SURFACE; CELL SURVIVAL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONFUSION; CONSCIOUSNESS DISORDER; DISEASE COURSE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; INFLAMMATORY CELL; MALE; MILD OROFACIAL DYSKINESIAS; NERVE CELL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL DYSKINESIA; PLEOCYTOSIS; PRIORITY JOURNAL; SEIZURE; SEPSIS; SYNAPSE; ANIMAL; BRAIN; CELL CULTURE; DIAGNOSTIC IMAGING; ENCEPHALITIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOLOGY; RAT; YOUNG ADULT;

ADULT; ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BRAIN; CELLS, CULTURED; ENCEPHALITIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; NERVE TISSUE PROTEINS; RATS; SYNAPSES; YOUNG ADULT;

EID: 84974718916     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002775     Document Type: Article

References (35)

1. Vora NM, Holman RC, Mehal JM, Steiner CA, Blanton J, Sejvar J Burden of Encephalitis-Associated Hospitalizations in the United States, 1998-2010. Neurology 2014; 82: 443-451
2. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43: 1565-1577
3. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-Term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-165
4. Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 2015; 15: 1391-1419
5. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-Nmethyl-D-Aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36
6. Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann NY Acad Sci 2015; 1338: 94-114
7. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30: 5866-5875
8. Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-Talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 2012; 135: 1606-1621
9. Peng X, Hughes EG, Moscato EH, Parsons TD, Dalmau J, Balice-Gordon RJ. Cellular plasticity induced by anti-Alphaamino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol 2015; 77: 381-398
10. Jain A, Lancaster E, Dalmau J, Balice-Gordon RJ. Autoantibodies in the CSF of anti-GABA receptor encephalitis patients block activation of GABA receptors in vitro (abstract M116, 140th annual meeting of the American Neurological Association). Ann Neurol 2015; 78(suppl 19): S77
11. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903-911
12. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098
13. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65: 424-434
14. Buchhalter JR, Dichter MA. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res Bull 1991; 26: 333-338
15. Planaguma J, Leypoldt F, Mannara F, et al. Human N-methyl D-Aspartate receptor antibodies alter memory and behaviour in mice. Brain 2015; 138: 94-109
16. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014; 13: 276-286
17. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-Associated encephalitides: clues for pathogenesis. Brain 2012; 135: 1622-1638
18. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011; 77: 589-593
19. Krueger DD, Tuffy LP, Papadopoulos T, Brose N. The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Curr Opin Neurobiol 2012; 22: 412-422
20. Siddiqui TJ, Pancaroglu R, Kang Y, Rooyakkers A, Craig AM. LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J Neurosci 2010; 30: 7495-7506
21. Aoto J, Martinelli DC, Malenka RC, Tabuchi K, Sudhof TC. Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell 2013; 154: 75-88
22. Missler M, Zhang W, Rohlmann A, et al. Alpha-neurexins couple Ca21 channels to synaptic vesicle exocytosis. Nature 2003; 423: 939-948
23. Aoto J, Foldy C, Ilcus SM, Tabuchi K, Sudhof TC. Distinct circuit-dependent functions of presynaptic neurexin-3 at GABAergic and glutamatergic synapses. Nat Neurosci 2015; 18: 997-1007
24. Gauthier J, Siddiqui TJ, Huashan P, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011; 130: 563-573
25. Rujescu D, Ingason A, Cichon S, et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009; 18: 988-996
26. Ikeda M, Aleksic B, Kinoshita Y, et al. Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry 2011; 69: 472-478
27. Feng J, Schroer R, Yan J, et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 2006; 409: 10-13
28. Liu Y, Hu Z, Xun G, et al. Mutation analysis of the NRXN1 gene in a Chinese autism cohort. J Psychiatr Res 2012; 46: 630-634
29. Vaags AK, Lionel AC, Sato D, et al. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet 2012; 90: 133-141
30. Tom DS, Sanmarti-Vila L, Langnaese K, et al. Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. J Cell Biol 1998; 142: 499-509
31. Hayashi MK, Tang C, Verpelli C, et al. The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell 2009; 137: 159-171
32. Scheiffele P, Fan J, Choih J, Fetter R, Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000; 101: 657-669
33. Levinson JN, Chery N, Huang K, et al. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligininduced synaptic specificity. J Biol Chem 2005; 280: 17312-17319
34. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005; 58: 594-604
35. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10: 835-844